Pete Batesko

Biography

Pete Batesko is Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson.  In this position, Pete reports directly to Johnson & Johnson’s Chief Financial Officer, Dominic Caruso, and provides finance leadership to the Pharmaceuticals Group, supporting Joaquin Duato and Paul Stoffels, as a member of the Group Operating Committee. He assumed this position on August 1, 2016. Prior to taking this position, Pete served as Vice President, Group Finance and played a critical leadership role in the restructuring and transformation of our Medical Device Group.  Prior to this role, in June 2012, Pete was appointed Vice President, Group Finance for the DePuy Synthes Companies of Johnson & Johnson, where he managed all financial aspects of the Orthopaedic business worldwide and was a member of the Group Operating Committee. From 2006 to 2012, Pete served as the Worldwide Vice President and Chief Financial Officer for DePuy Orthopaedics, Inc. In that role, he assisted with the acquisition of Synthes and the creation of the world’s most comprehensive orthopaedic and neurological company. From 2003-2006, Pete was the Vice President of Finance and Chief Financial Officer for Ortho Biotech Products, L.P. During that tenure, he oversaw all financial areas including health care compliance, process excellence and was part of the team that returned PROCRIT® to growth. Pete has 35 years of Johnson & Johnson experience, beginning his career in 1981 as an auditor at headquarters in New Brunswick, New Jersey. From 1995 to 2003, he worked for Ortho-McNeil Pharmaceutical, Inc. as a controller. In that role, Pete led financial oversight of various groups including Business Development, Sales and Marketing.  During this time Pete was also a member of the team responsible for the acquisition of Centocor.  

Research Interest

 accounts